GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) » Definitions » Deferred Policy Acquisition Costs

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Deferred Policy Acquisition Costs


View and export this data going back to 2020. Start your Free Trial

What is Beijing Wantai Biological Pharmacy Enterprise Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Business Description

Traded in Other Exchanges
N/A
Address
No. 31, Science Park Road, Beiqing Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is an engaged in the research and development and production of biodiagnostic reagents and vaccines. The company produces chemiluminescence, nucleic acid, clinical biochemistry and other testing reagents and clinical inspection quality control products and vaccines. Its products include ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series.